ARCHIVES

UT-Houston Wins NIH Center Grant For Alternative Cancer Medicine Studies

This article is from The Cancer Letter archive.

Vol. 21 No. 42 | November 3, 1995

Download PDF Visit The Full Archive

Related Articles

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

July 29, 2011

Denosumab Demonstrates Superiority Over Zometa For Bone Metastases

August 28, 2009

Model Projects 54,900 New Lung Cancer Cases In 5 Years with Nationwide LDCT Screening

May 30, 2014

Professional Societes; ASCO’s Strength Is In Its Diversify, Lichtor Says

May 21, 1999

ASCO Urges Sustained Support For Cancer Research, Clinical Trials

March 27, 2009

FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview.

November 7, 2003